What does CUSIP 670002104 represent in this 13F holders report?

CUSIP 670002104 is the security identifier for NVAX - NOVAVAX INC - COM used to aggregate holder disclosures.

How many institutions held NVAX - NOVAVAX INC - COM in Q1 2018?

145 institutional investors reported NVAX - NOVAVAX INC - COM for Q1 2018. Use the holders table for investor-level position and value details.

NOVAVAX INC - COM (NVAX)

CUSIP: 670002104

Q1 2018 13F Holders as of 31 Mar 2018

Security type / class: Equity / COM
Total 13F shares: 155,596,178
Total 13F value: $326,746,477
Share change: +29,075,655
Put/Call ratio: 108%
SEC-reported price per share: $2.10
Number of holders: 145
Value change: +$62,994,229
Number of buys: 78
Number of sells: 53

Security key

670002104

Report period

Q1 2018

Institutions

145

Top holders

NVAX full security history Ownership snapshot Full 13F holder table NOVAVAX INC SEC filings NOVAVAX INC company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of NVAX - NOVAVAX INC - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

BlackRock Finance, Inc.

Disclosed value leader

BlackRock Finance, Inc.

Comparable rows

0/15

Latest evidence

31 Dec 2017

13F Highest disclosed value: $30,828,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

BlackRock Finance, Inc. has the largest disclosed position value at $30.83M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BlackRock Finance, Inc.'s linked filing trail.

Disclosed position value Top 5

BlackRock Finance, Inc. $30.83M

VANGUARD GROUP INC $17.84M

STATE STREET CORP $15.01M

BB BIOTECH AG $10.33M

JPMORGAN CHASE & CO $8.46M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
BlackRock Finance, Inc.	13F Company 13F	— denominator unverified	$30,828,000 24,863,285 shares	—	31 Dec 2017
VANGUARD GROUP INC	13F Company 13F	— denominator unverified	$17,839,000 14,386,865 shares	—	31 Dec 2017
STATE STREET CORP	13F Company 13F	— denominator unverified	$15,014,000 12,109,908 shares	—	31 Dec 2017
BB BIOTECH AG	13F Company 13F	— denominator unverified	$10,329,000 8,330,000 shares	—	31 Dec 2017
JPMORGAN CHASE & CO	13F Company 13F	— denominator unverified	$8,464,000 6,825,664 shares	—	31 Dec 2017
FMR LLC	13F Company 13F	— denominator unverified	$6,832,000 5,509,637 shares	—	31 Dec 2017

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2018

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

145

155,596,178

Rows available

145

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2018 vs Q1 2018 Across Filers

Q1 2018 holders

145

Q1 2018 holders

145

Holder diff

Investor	Q1 2018 Shares	Q1 2018 Shares	Share Diff	Share Chg %	Q1 2018 value	Q1 2018 value	Value change	Value Chg %